Articles

  1. Integrated Solutions For Your Mammalian-Based Biologics 6/2/2025

    A leading CDMO offers integrated development and manufacturing solutions for mammalian-based biologics, including mAbs, ADCs, and biosimilars, with strong quality, flexibility, and regulatory compliance.

  2. Streamlining ADC Development: Advantage Of An All-In-One Solution 6/2/2025

    Antibody-drug conjugate (ADC) development requires tightly integrated manufacturing. Streamlined, end-to-end solutions reduce complexity, improve quality, and accelerate time-to-market.

  3. Unparalleled Efficiency And Precision In HPAPIs 5/22/2025

    Our state-of-the-art HPAPI manufacturing facilities offer you an exceptional experience, setting a new standard for quality and efficiency in the industry.

  4. Flow Chemistry Experiments Of Highly Hazardous Butyl Lithium Reactions 5/22/2025

    By adopting flow chemistry for a production platform that reduces utility costs and solvent consumption, researchers can overcome the risks and challenges of Butyl Lithium chemistry.

  5. Handling Protocols: Key Considerations In The Highly Potent API Market 5/12/2025

    Explore the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.

  6. Drug Product Manufacturing: Scaling Product From Bench To Market 5/7/2025

    Curia offers comprehensive development and manufacturing services to meet needs through the entire lifecycle of your sterile drug product. Leverage our in-depth expertise and capabilities at any scale, from early clinical through large-scale commercial.

  7. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

    Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

  8. 5 Steps To Design A Microbiological Performance Qualification For Facilities 4/21/2025

    Explore five steps to design an EMPQ for sterile manufacturing: classification, protocol drafting, cleaning evaluation, disinfectant efficacy testing, and continuous improvement.

  9. Control Strategies And Method Development For Nitrosamines In APIs And Drug Products 4/15/2025

    Explore regulatory insights, analytical strategies, and real-world case studies for effective nitrosamine control in APIs and drug products.

  10. Comprehensive DoE Capabilities For Synthesis, Process Development, And NCE's 4/15/2025

    Our data-driven DoE strategies are designed to deliver higher yields, faster turnaround times, and cost-effective solutions tailored to your development goals.